Advanced search
1 file | 183.28 KB Add to list

Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire

Author
Organization
Abstract
The purpose of this study was to describe the results of Nd:YAG laser application in hereditary hemorrhagic telangiectasia (HHT) patients and to measure the Health-Related Quality of Life (HR-QoL) in patients with HHT before and after Nd:YAG laser application in a prospective, clinical trial at a university hospital. Twenty-seven consecutive patients with HHT and mild to moderate degrees of epistaxis were followed-up for 2 years after Nd:YAG laser treatments. Recurrence of epistaxis after Nd:YAG laser application and measurement of HR-QoL using the International Quality of Life Assessment questionnaire, version 1.1 (IQOLA 1.1), was found. Eight patients (30%) received only one Nd:YAG laser treatment, 15 (56%) had a recurrence and received a second treatment and 4 (14%) had two recurrences and received three Nd:YAG laser treatments. HR-QoL was improved 2 years after the first Nd:YAG laser application in both its Physical Health Dimension (47.5 +/- 2.9 vs. 38.1 +/- 2.3 before treatment, P < 0.05) and Mental Health Dimension (45.1 +/- 2.7 vs. 39.6 +/- 2.4 before treatment, P < 0.05). Although no curative treatment for HHT exists, Nd:YAG laser treatment seems to constitute a simple and efficient method of epistaxis control, resulting in a significant improvement in quality of life.
Keywords
Nd, hereditary hemorrhagic telangiectasia, YAG laser, quality of life, ARGON PLASMA COAGULATION, WEBER-RENDU DISEASE, MUCOSA

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 183.28 KB

Citation

Please use this url to cite or link to this publication:

MLA
Karapantzos, Ilias, Nikolaos Tsimpiris, Dimitrios G Goulis, et al. “Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia by Nd:YAG Laser and Quality of Life Assessment Using the HR-QoL Questionnaire.” EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY 262.10 (2005): 830–833. Print.
APA
Karapantzos, I., Tsimpiris, N., Goulis, D. G., Van Hoecke, H., Van Cauwenberge, P., & Danielieds, V. (2005). Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 262(10), 830–833.
Chicago author-date
Karapantzos, Ilias, Nikolaos Tsimpiris, Dimitrios G Goulis, Helen Van Hoecke, Paul Van Cauwenberge, and Vasilis Danielieds. 2005. “Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia by Nd:YAG Laser and Quality of Life Assessment Using the HR-QoL Questionnaire.” European Archives of Oto-rhino-laryngology 262 (10): 830–833.
Chicago author-date (all authors)
Karapantzos, Ilias, Nikolaos Tsimpiris, Dimitrios G Goulis, Helen Van Hoecke, Paul Van Cauwenberge, and Vasilis Danielieds. 2005. “Management of Epistaxis in Hereditary Hemorrhagic Telangiectasia by Nd:YAG Laser and Quality of Life Assessment Using the HR-QoL Questionnaire.” European Archives of Oto-rhino-laryngology 262 (10): 830–833.
Vancouver
1.
Karapantzos I, Tsimpiris N, Goulis DG, Van Hoecke H, Van Cauwenberge P, Danielieds V. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2005;262(10):830–3.
IEEE
[1]
I. Karapantzos, N. Tsimpiris, D. G. Goulis, H. Van Hoecke, P. Van Cauwenberge, and V. Danielieds, “Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire,” EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, vol. 262, no. 10, pp. 830–833, 2005.
@article{335844,
  abstract     = {The purpose of this study was to describe the results of Nd:YAG laser application in hereditary hemorrhagic telangiectasia (HHT) patients and to measure the Health-Related Quality of Life (HR-QoL) in patients with HHT before and after Nd:YAG laser application in a prospective, clinical trial at a university hospital. Twenty-seven consecutive patients with HHT and mild to moderate degrees of epistaxis were followed-up for 2 years after Nd:YAG laser treatments. Recurrence of epistaxis after Nd:YAG laser application and measurement of HR-QoL using the International Quality of Life Assessment questionnaire, version 1.1 (IQOLA 1.1), was found. Eight patients (30%) received only one Nd:YAG laser treatment, 15 (56%) had a recurrence and received a second treatment and 4 (14%) had two recurrences and received three Nd:YAG laser treatments. HR-QoL was improved 2 years after the first Nd:YAG laser application in both its Physical Health Dimension (47.5 +/- 2.9 vs. 38.1 +/- 2.3 before treatment, P < 0.05) and Mental Health Dimension (45.1 +/- 2.7 vs. 39.6 +/- 2.4 before treatment, P < 0.05). Although no curative treatment for HHT exists, Nd:YAG laser treatment seems to constitute a simple and efficient method of epistaxis control, resulting in a significant improvement in quality of life.},
  author       = {Karapantzos, Ilias and Tsimpiris, Nikolaos  and Goulis, Dimitrios G and Van Hoecke, Helen and Van Cauwenberge, Paul and Danielieds, Vasilis},
  issn         = {0937-4477},
  journal      = {EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY},
  keywords     = {Nd,hereditary hemorrhagic telangiectasia,YAG laser,quality of life,ARGON PLASMA COAGULATION,WEBER-RENDU DISEASE,MUCOSA},
  language     = {eng},
  number       = {10},
  pages        = {830--833},
  title        = {Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd:YAG laser and quality of life assessment using the HR-QoL questionnaire},
  url          = {http://dx.doi.org/10.1007/s00405-004-0911-0},
  volume       = {262},
  year         = {2005},
}

Altmetric
View in Altmetric
Web of Science
Times cited: